Design, organocatalytic synthesis, and bioactivity evaluation of enantiopure fluorinated LpxC inhibitors

Enantiopure compounds with a strategically incorporated fluorine atom intended to enhance LpxC inhibition have been synthesized using an organocascade fluorination reaction as the key step. These are the first low molecular weight LpxC inhibitors to contain a fluorine atom on a critically important...

Full description

Saved in:
Bibliographic Details
Published inOrganic & biomolecular chemistry Vol. 18; no. 3; pp. 5867 - 5878
Main Authors Rodríguez-Alvarado, Melanie, Russo, Riccardo, Connell, Nancy D, Brenner-Moyer, Stacey E
Format Journal Article
LanguageEnglish
Published CAMBRIDGE Royal Soc Chemistry 05.08.2020
Royal Society of Chemistry
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Enantiopure compounds with a strategically incorporated fluorine atom intended to enhance LpxC inhibition have been synthesized using an organocascade fluorination reaction as the key step. These are the first low molecular weight LpxC inhibitors to contain a fluorine atom on a critically important chiral center that is substituted with two pharmacophoric moieties, and were thusly designed to provide new SAR data for this class of compounds. Fluorinated compounds were evaluated against ESKAPE pathogens and exhibited MICs of ≤12.5 μg mL −1 against Pseudomonas aeruginosa . Enantiopure compounds designed to enhance LpxC inhibition via strategic incorporation of a fluorine atom were synthesized using an organocascade fluorination reaction as the key step.
Bibliography:H
Electronic supplementary information (ESI) available: Additional experimental details and compound characterization, table of bacteria strains used in this study. Copies of
1
13
10.1039/d0ob01125h
C, and HPLC spectra. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1477-0520
1477-0539
1477-0539
DOI:10.1039/d0ob01125h